HARARE – Zimbabwe is suffering a shortage of imported second-line drugs to treat HIV victims due to insufficient foreign exchange. Health activists say thousands of patients on publicly-funded treatment programmes are at risk because of the shortage of Abacavir, forcing them to take lower dosages or none at all. Patients are being given a week’s…
To access this content, please purchase a subscription by clicking the button below and select a package of your choice!
Subscriptions